Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | |
| Cash Flows From Operating Activities | |
| Net Income | -181,384 |
| Depreciation Amortization | 9,901 |
| Other Working Capital | 28,118 |
| Other Operating Activity | 25,615 |
| Operating Cash Flow | $-117,750 |
| Cash Flows From Investing Activities | |
| PPE Investments | -3,437 |
| Other Investing Activity | -54,288 |
| Investing Cash Flow | $-57,725 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 91,327 |
| Financing Cash Flow | $91,327 |
| Beginning Cash Position | 265,979 |
| End Cash Position | 181,831 |
| Net Cash Flow | $-84,148 |
| Free Cash Flow | |
| Operating Cash Flow | -117,750 |
| Free Cash Flow | -117,750 |